Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Asahi Glass Announces Acquisition of Major European Biotech Pharmaceutical Company

Filed Under: Pharma Tagged With: , , , , , , ,

Asahi Glass Co. Ltd. (TYO:5201) announced on Dec. 20 that it will acquire CMC Biologics, a major biopharmaceutical contract development…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Asahi Kasei Medical to Enter Pharmaceutical CDMO Business
Asahi Kasei Medical to Enter Pharmaceutical CDMO Business
AGC Looks to Advance Into Gene and Cell Therapy Business With Tender Offer for MolMed
AGC Looks to Advance Into Gene and Cell Therapy Business…
Chitose Bio Evolution Moves Forward on Chemical, Bio-CDMO Mass Production in Japan
Chitose Bio Evolution Moves Forward on Chemical, Bio-CDMO…
Taiwan Looks to Establish CDMOs for mRNA Technology
Taiwan Looks to Establish CDMOs for mRNA Technology
AGC in Race to Bolster CDMO Operations Across US, Europe and Japan
AGC in Race to Bolster CDMO Operations Across US, Europe and…
Overview of Major M&A Projects Under Japanese Chemical Companies in 2019
Overview of Major M&A Projects Under Japanese Chemical…